Swiss edition

Data as at end-April 2017

UBS Equity USA Enhanced P-acc

Fund Fact Sheet
UBS Quant Funds > Equities

Fund description Performance (basis USD, net of fees)1

Actively managed equity portfolio that invests in Indexed on the basis of month-end data in %
225 +100
US companies.
Application of a quantitative approach based 200 +80

primarily on fundamental factors to exploit market 175 +60

anomalies and avoid cluster risks. 150 +40
The degree of relevance the model accords to each
125 +20
of the above factors is adapted continually in line
with market conditions. 100 0

75 -20

50 -40

25 -60
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

Indexed fund performance net of fees (left-hand scale)

Fund performance per year in % net of fees (right-hand scale)
Indexed index performance (left-hand scale)

Name of fund UBS (Lux) Equity SICAV - USA

Enhanced (USD) in % 2013 2014 2015 2016 2017 Apr. 5 years p.a. 5
Share class UBS (Lux) Equity SICAV - USA Enhanced YTD2 2017 years
(USD) P-acc Fund (USD) 31.12 12.21 -0.60 7.96 6.23 0.57 72.26 11.49
ISIN LU0246276595 Ref. Index3 31.79 12.69 0.69 10.89 7.19 1.05 83.15 12.87
Securities no. 2 468 895 1 These figures refer to the past. Past performance is not a reliable indicator of future results. The
performance shown does not take account of any commissions and costs charged when subscribing to
Bloomberg UBSUSQB LX and redeeming units. Source for all data and charts (if not indicated otherwise): UBS Asset Management
2 YTD: year-to-date (since beginning of the year)
Currency of fund USD 3 Reference Index in currency of share class (without costs)
Currency of share class USD Name changed on 30.03.2015: from UBS (Lux) Equity SICAV USA Quantitative (USD) to UBS (Lux) Equity
Fund type open-end SICAV USA Enhanced (USD).

Launch date 19.05.2006

Issue/redemption daily Fund statistics
Swing pricing yes Net asset value (USD, 28.04.2017) 200.92
Accounting year end 31 May Last 12 months (USD) high 202.42
Reference Index MSCI USA (r) Last 12 months (USD) low 168.41
Distribution Reinvestment Total fund assets (USD m) (28.04.2017) 1 036.41
Management fee p.a. 0.72% Share class assets (USD m) 288.33
Total expense ratio (TER) p.a.1 0.97%
1 as at 31.05.2016
3 years 5 years
Beta 1.00 1.00
Volatility1
Fund 10.46% 10.28%
Reference Index 10.38% 10.17%
Sharpe ratio 0.69 1.08
Risk free rate 0.47% 0.37%
1 Annualised standard deviation

For questions about the Fund:

UBS Fund Infoline: 0800 899 899
Internet: www.ubs.com/funds updated daily on your funds
in our UBS Funds App.
Contact your client advisor
Portfolio management representatives
Jeremy Raccio
12
UBS Equity USA Enhanced P-acc

Sector exposure (%) 10 largest equity positions (%)

Fund Deviation from index Fund Index
Information Technology 22.28 -0.2 Apple Inc 4.40 3.57
Financials 17.07 +3.2 Microsoft Corp 2.00 2.36
Health Care 15.96 +2.0 Bank of America Corp 2.00 1.10
Consumer Discretionary 11.21 -1.9 AT&T Inc 1.97 1.13
Consumer Staples 10.75 +1.6 Johnson & Johnson 1.97 1.56
Industrials 7.73 -2.0 Alphabet Inc 1.64 1.28
JPMorgan Chase & Co 1.62 1.45
Utilities 5.14 +2.0
Philip Morris International Inc 1.58 0.80
Energy 5.12 -1.2
PepsiCo Inc 1.54 0.76
Telecommunication Services 2.78 +0.5 Wal-Mart Stores Inc 1.45 0.54
Others 1.96 -4.1

Key benefits Risks

A simple way to gain exposure to US equity markets
The use of quantitative models gives investors access to a
broad range of investment opportunities as over 1,000 US
stocks are covered.
Investors can also profit from additional diversification thanks
to the quantitative investment approach applied.
The fund is managed by a specialised quant investments
team.
UBS Quant Funds invest in equities and may therefore be
subject to high fluctuations in value. For this reason, an
investment horizon of at least five years and corresponding risk
tolerance and capacity are required. As these UBS funds pursue
an active management style, each fund's performance can
deviate from that of its reference index. All investments are
subject to market fluctuations. Every fund has specific risks,
which can significantly increase under unusual market
conditions. The fund can use derivatives, which may result in
additional risks (particularly counterparty risk).

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Representative in Switzerland for UBS funds established under foreign law: UBS Fund
Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Paying agent: UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich. Prospectuses, simplified prospectuses or Key investor
information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS AG, P.O. Box,
CH-4002 Basel or from UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Before investing in a product please read the latest prospectus carefully and thoroughly.
Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States.
The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not
a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions
and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or
28662|51225

decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any
specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information
purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not
indicated otherwise): UBS Asset Management
UBS 2017. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
22
 Swiss edition
Data as at end-April 2017

UBS Equity USA Enhanced Q-acc

Fund Fact Sheet
UBS Quant Funds > Equities

Fund description Performance (basis USD, net of fees)1

Actively managed equity portfolio that invests in Indexed on the basis of month-end data in %
125 +15
US companies.
Application of a quantitative approach based 120 +12

primarily on fundamental factors to exploit market 115 +9

anomalies and avoid cluster risks. 110 +6
The degree of relevance the model accords to each
105 +3
of the above factors is adapted continually in line
with market conditions. 100 0

95 -3

90 -6

85 -9
2015 2016 2017

Indexed fund performance net of fees (left-hand scale)

Fund performance per year in % net of fees (right-hand scale)
Indexed index performance (left-hand scale)

Name of fund UBS (Lux) Equity SICAV - USA

Enhanced (USD) in % 2013 2014 2015 2016 2017 LTD3 1 year p.a. 2
Share class UBS (Lux) Equity SICAV - USA Enhanced YTD2 years
(USD) Q-acc Fund (USD) n.a. n.a. n.a. 8.23 6.31 15.59 15.47 n.a.
ISIN LU0399034585 Ref. Index4 n.a. n.a. n.a. 10.89 7.19 20.66 17.41 n.a.
Securities no. 28 306 341 1 These figures refer to the past. Past performance is not a reliable indicator of future results. The
performance shown does not take account of any commissions and costs charged when subscribing to
Bloomberg UBUEQAU LX and redeeming units. Source for all data and charts (if not indicated otherwise): UBS Asset Management
2 YTD: year-to-date (since beginning of the year)
Currency of fund USD 3 LTD: launch-to-date
Currency of share class USD 4 Reference Index in currency of share class (without costs)

Fund type open-end Name changed on 30.03.2015: from UBS (Lux) Equity SICAV USA Quantitative (USD) to UBS (Lux) Equity
SICAV USA Enhanced (USD).
Launch date 12.10.2015
Issue/redemption daily
Fund statistics
Swing pricing yes
Net asset value (USD, 28.04.2017) 115.59
Accounting year end 31 May
Reference Index MSCI USA (r) Last 12 months (USD) high 116.40
Distribution Reinvestment Last 12 months (USD) low 96.68
Management fee p.a. 0.52% Total fund assets (USD m) (28.04.2017) 1 036.41
Total expense ratio (TER) p.a.1 0.75% Share class assets (USD m) 0.73
1 as at 31.05.2016

3 years 5 years
Beta n.a. n.a.
Volatility1
Fund n.a. n.a.
Reference Index n.a. n.a.
Sharpe ratio n.a. n.a.
Risk free rate n.a. n.a.
1 Annualised standard deviation

For questions about the Fund:

UBS Fund Infoline: 0800 899 899
Internet: www.ubs.com/funds
Contact your client advisor
Portfolio management representatives
Jeremy Raccio
12
UBS Equity USA Enhanced Q-acc

Sector exposure (%) 10 largest equity positions (%)

Fund Deviation from index Fund Index
Information Technology 22.28 -0.2 Apple Inc 4.40 3.57
Financials 17.07 +3.2 Microsoft Corp 2.00 2.36
Health Care 15.96 +2.0 Bank of America Corp 2.00 1.10
Consumer Discretionary 11.21 -1.9 AT&T Inc 1.97 1.13
Consumer Staples 10.75 +1.6 Johnson & Johnson 1.97 1.56
Industrials 7.73 -2.0 Alphabet Inc 1.64 1.28
JPMorgan Chase & Co 1.62 1.45
Utilities 5.14 +2.0
Philip Morris International Inc 1.58 0.80
Energy 5.12 -1.2
PepsiCo Inc 1.54 0.76
Telecommunication Services 2.78 +0.5 Wal-Mart Stores Inc 1.45 0.54
Others 1.96 -4.1

Key benefits Risks

A simple way to gain exposure to US equity markets
The use of quantitative models gives investors access to a
broad range of investment opportunities as over 1,000 US
stocks are covered.
Investors can also profit from additional diversification thanks
to the quantitative investment approach applied.
The fund is managed by a specialised quant investments
team.
UBS Quant Funds invest in equities and may therefore be
subject to high fluctuations in value. For this reason, an
investment horizon of at least five years and corresponding risk
tolerance and capacity are required. As these UBS funds pursue
an active management style, each fund's performance can
deviate from that of its reference index. All investments are
subject to market fluctuations. Every fund has specific risks,
which can significantly increase under unusual market
conditions. The fund can use derivatives, which may result in
additional risks (particularly counterparty risk).

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Representative in Switzerland for UBS funds established under foreign law: UBS Fund
Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Paying agent: UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich. Prospectuses, simplified prospectuses or Key investor
information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS AG, P.O. Box,
CH-4002 Basel or from UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Before investing in a product please read the latest prospectus carefully and thoroughly.
Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States.
The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not
100008365|51225

a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions
and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or
decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any
specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information
purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not
indicated otherwise): UBS Asset Management
UBS 2017. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
22
 Swiss edition
Data as at end-April 2017

UBS Equity USA Enhanced (EUR hedged) P-acc

Fund Fact Sheet
UBS Quant Funds > Equities

Fund description Performance (basis EUR, net of fees)1

Actively managed equity portfolio that invests in Indexed on the basis of month-end data in %
125 +15
US companies.
Application of a quantitative approach based 120 +12
primarily on fundamental factors to exploit market
115 +9
anomalies and avoid cluster risks.
The degree of relevance the model accords to each 110 +6
of the above factors is adapted continually in line
105 +3
with market conditions.
The exchange rate risk between USD and EUR is 100 0

largely hedged. 95 -3

90 -6
2015 2016 2017

Indexed fund performance net of fees (left-hand scale)

Fund performance per year in % net of fees (right-hand scale)

Name of fund UBS (Lux) Equity SICAV - USA

Enhanced (USD) in % 2013 2014 2015 2016 2017 LTD3 2 years p.a. 2
Share class UBS (Lux) Equity SICAV - USA Enhanced YTD2 years
(USD) (EUR hedged) P-acc Fund (EUR) n.a. n.a. n.a. 6.73 5.63 14.40 11.27 5.49
1 These figures refer to the past. Past performance is not a reliable indicator of future results. The
ISIN LU1157384881 performance shown does not take account of any commissions and costs charged when subscribing to
Securities no. 26 384 256 and redeeming units. Source for all data and charts (if not indicated otherwise): UBS Asset Management
2 YTD: year-to-date (since beginning of the year)
Bloomberg UUQGPHA LX 3 LTD: launch-to-date
Currency of fund USD Name changed on 30.03.2015: from UBS (Lux) Equity SICAV USA Quantitative (USD) to UBS (Lux) Equity
SICAV USA Enhanced (USD).
Currency of share class EUR
Fund type open-end
Launch date 07.01.2015 Fund statistics
Issue/redemption daily Net asset value (EUR, 28.04.2017) 114.40
Swing pricing yes Last 12 months (EUR) high 115.61
Accounting year end 31 May Last 12 months (EUR) low 97.06
Reference Index No representative reference index is Total fund assets (EUR m) (28.04.2017) 951.75
available
Share class assets (EUR m) 239.94
Distribution Reinvestment
Management fee p.a. 0.72%
Total expense ratio (TER) p.a.1 0.98% 3 years 5 years
1 as at 31.05.2016 Volatility1
Fund n.a. n.a.
Sharpe ratio n.a. n.a.
Risk free rate n.a. n.a.
1 Annualised standard deviation

For questions about the Fund:

UBS Fund Infoline: 0800 899 899
Internet: www.ubs.com/funds
Contact your client advisor
Portfolio management representatives
Jeremy Raccio
12
UBS Equity USA Enhanced (EUR hedged) P-acc

Sector exposure (%) 10 largest equity positions (%)

Fund Fund
Information Technology 22.3 Apple Inc 4.40
Financials 17.1 Microsoft Corp 2.00
Health Care 16.0 Bank of America Corp 2.00
Consumer Discretionary 11.2 AT&T Inc 1.97
Consumer Staples 10.8 Johnson & Johnson 1.97
Industrials 7.7 Alphabet Inc 1.64
JPMorgan Chase & Co 1.62
Utilities 5.1
Philip Morris International Inc 1.58
Energy 5.1
PepsiCo Inc 1.54
Telecommunication Services 2.8 Wal-Mart Stores Inc 1.45
Materials 2.0

Key benefits Risks

A simple way to gain exposure to US equity markets
The use of quantitative models gives investors access to a
broad range of investment opportunities as over 1,000 US
stocks are covered.
Investors can also profit from additional diversification thanks
to the quantitative investment approach applied.
The fund is managed by a specialised quant investments
team.
UBS Quant Funds invest in equities and may therefore be
subject to high fluctuations in value. For this reason, an
investment horizon of at least five years and corresponding risk
tolerance and capacity are required. As these UBS funds pursue
an active management style, each fund's performance can
deviate from that of its reference index. All investments are
subject to market fluctuations. Every fund has specific risks,
which can significantly increase under unusual market
conditions. The fund can use derivatives, which may result in
additional risks (particularly counterparty risk).

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Representative in Switzerland for UBS funds established under foreign law: UBS Fund
Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Paying agent: UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich. Prospectuses, simplified prospectuses or Key investor
information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS AG, P.O. Box,
CH-4002 Basel or from UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Before investing in a product please read the latest prospectus carefully and thoroughly.
Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States.
The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not
a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions
1099257|51225

and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or
decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any
specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information
purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not
indicated otherwise): UBS Asset Management
UBS 2017. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
22